Goldman Sachs Group Inc Macrogenics Inc Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 698,288 shares of MGNX stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

698,288

Previous 197,696 253.21%

Holding current value

$1.06 Million

Previous $251,000 236.25%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.06 - $1.79 $530,627 - $896,059	500,592 Added 253.21%	698,288 $844,000
Q1 2025 May 09, 2025	SELL	$1.26 - $3.49 $193,334 - $535,505	-153,440 Reduced 43.7%	197,696 $251,000
Q4 2024 Feb 11, 2025	BUY	$3.18 - $4.46 $390,154 - $547,197	122,690 Added 53.71%	351,136 $1.14 Million
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $744,240 - $1.38 Million	-248,080 Reduced 52.06%	228,446 $751,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $430,965 - $2.41 Million	130,201 Added 37.6%	476,526 $2.03 Million
Q1 2024 May 15, 2024	SELL	$9.77 - $21.47 $2.65 Million - $5.83 Million	-271,638 Reduced 43.96%	346,325 $5.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.48 - $10.11 $519,254 - $1.17 Million	115,905 Added 23.09%	617,963 $5.94 Million
Q3 2023 May 14, 2024	SELL	$4.48 - $6.19 $519,254 - $717,451	-115,905 Reduced 18.76%	502,058 $2.34 Million
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $463,285 - $640,120	103,412 Added 25.94%	502,058 $2.34 Million
Q2 2023 May 14, 2024	BUY	$4.62 - $7.54 $310,699 - $507,072	67,251 Added 20.29%	398,646 $2.13 Million
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $310,699 - $507,072	67,251 Added 20.29%	398,646 $2.13 Million
Q1 2023 May 14, 2024	SELL	$4.82 - $7.24 $832,274 - $1.25 Million	-172,671 Reduced 34.26%	331,395 $2.38 Million
Q1 2023 May 11, 2023	SELL	$4.82 - $7.24 $832,274 - $1.25 Million	-172,671 Reduced 34.26%	331,395 $2.38 Million
Q4 2022 May 14, 2024	BUY	$3.34 - $6.98 $137,043 - $286,396	41,031 Added 8.86%	504,066 $3.38 Million
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $137,043 - $286,396	41,031 Added 8.86%	504,066 $3.38 Million
Q3 2022 May 14, 2024	SELL	$3.01 - $5.22 $366,527 - $635,639	-121,770 Reduced 20.82%	463,035 $1.6 Million
Q3 2022 Nov 10, 2022	SELL	$3.01 - $5.22 $366,527 - $635,639	-121,770 Reduced 20.82%	463,035 $0
Q2 2022 May 14, 2024	SELL	$2.25 - $9.99 $74,605 - $331,248	-33,158 Reduced 5.37%	584,805 $1.73 Million
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $575,700 - $2.56 Million	255,867 Added 77.79%	584,805 $1.73 Million
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $607,993 - $1.27 Million	-74,876 Reduced 18.54%	328,938 $2.9 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $1.47 Million - $2.03 Million	92,615 Added 29.76%	403,814 $6.48 Million
Q3 2021 Nov 10, 2021	BUY	$19.74 - $28.7 $6.14 Million - $8.93 Million	311,199 New	311,199 $6.52 Million

Others Institutions Holding MGNX

# of Institutions

118

Shares Held

52.3M

Call Options Held

55.3K

Put Options Held

35.9K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $93.4M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Macrogenics Inc Transaction History